Sally Stanage Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 815 Locust St, Yankton, SD 57078 Phone: 605-665-7392 |
Jaime L Ness, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2301 Valley Rd, Yankton, SD 57078 Phone: 605-665-1760 |
Mrs. Madison Henseler, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 607 E 16th St, Yankton, SD 57078 Phone: 605-661-8885 |
Kourtney Lou Colpitts Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 208 W 21st St, Yankton, SD 57078 Phone: 605-665-5765 |
Mrs. Stephanie Kanaly Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1300 Maple St, Yankton, SD 57078 Phone: 605-661-9337 |
Mrs. Sara Elizabeth Gilmore, MA, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2907 Mulligan Dr, Yankton, SD 57078 Phone: 605-665-1049 |
Hannah Downing, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 208 W 21st St, Yankton, SD 57078 Phone: 605-857-0593 |
Mrs. Jean Friedenbach, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1214 Mulberry St, Yankton, SD 57078 Phone: 605-665-2282 |
Matthew Lingo, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2410 West City Limits Road, Yankton, SD 57078 Phone: 605-665-3999 |
Lindsi Frahm Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2410 W City Limits Rd, Yankton, SD 57078 Phone: 605-665-3980 |
News Archive
The recent approval of pembrolizumab (Keytruda) in recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) following progression on a platinum-based chemotherapy was a significant advancement for the disease.
Researchers of Peter the Great St.Petersburg Polytechnic University, in collaboration with the Almazov National Medical Research Centre, developed an artificial intelligence system for analyzing endoscopic images (mucous membranes of organs).
Cancer immunotherapy using "designer" immune cells has revolutionized cancer treatment in recent years. In this type of therapy, T cells, a type of white blood cell, are collected from a patient's blood and subjected to genetic engineering to produce T cells carrying a synthetic molecule termed chimeric antigen receptor (CAR) that is designed to enable T cells to recognize and destroy cancer cells.
A vaccine combining centralized ancestral genes from four major influenza strains appears to provide broad protection against the dangerous ailment, according to new research by a team from the Nebraska Center for Virology.
› Verified 4 days ago